AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Xlstat for hcc students8/17/2023 Clinically available small-molecule inhibitors HLM6474 and SIS3 specifically targeting the oncofetal drivers extensively down-regulated subtype-specific developmental signaling and significantly inhibited tumorigenicity. Two subtypes of liver cancer with different oncofetal properties and upstream oncogenic drivers were found in clinical patients with poor prognosis. In a recent study, a dynamic oncofetal-like gene expression signature during liver development was identified from an in vitro hepatocyte differentiation model. Poorly differentiated hepatocellular carcinomas (HCCs) usually show phenotypic resemblance to their ancestral precursor cells and are associated with poor clinical outcome. Developmental signaling pathways play important roles in cancer initiation and therapeutic resistance.
0 Comments
Read More
Leave a Reply. |